INmune Bio Statistics Share Statistics INmune Bio has 26.59M
shares outstanding. The number of shares has increased by 19.9%
in one year.
Shares Outstanding 26.59M Shares Change (YoY) 19.9% Shares Change (QoQ) 14.54% Owned by Institutions (%) 23.5% Shares Floating 18.72M Failed to Deliver (FTD) Shares 1,139 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 3.33M, so 12.51% of the outstanding
shares have been sold short.
Short Interest 3.33M Short % of Shares Out 12.51% Short % of Float 15.07% Short Ratio (days to cover) 3.9
Valuation Ratios The PE ratio is -2.21 and the forward
PE ratio is -1.51.
INmune Bio's PEG ratio is
-0.08.
PE Ratio -2.21 Forward PE -1.51 PS Ratio 6652.75 Forward PS 553 PB Ratio 2.9 P/FCF Ratio -2.79 PEG Ratio -0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for INmune Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.14,
with a Debt / Equity ratio of 0.01.
Current Ratio 3.14 Quick Ratio 3.14 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.08K Profits Per Employee $-3.24M Employee Count 13 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -61.9% in the
last 52 weeks. The beta is 1.05, so INmune Bio's
price volatility has been higher than the market average.
Beta 1.05 52-Week Price Change -61.9% 50-Day Moving Average 2.26 200-Day Moving Average 5.68 Relative Strength Index (RSI) 48.64 Average Volume (20 Days) 1,593,371
Income Statement In the last 12 months, INmune Bio had revenue of 14K
and earned -42.08M
in profits. Earnings per share was -2.11.
Revenue 14K Gross Profit 14K Operating Income -42.63M Net Income -42.08M EBITDA -42.08M EBIT -42.63M Earnings Per Share (EPS) -2.11
Full Income Statement Balance Sheet The company has 20.92M in cash and 384K in
debt, giving a net cash position of 20.54M.
Cash & Cash Equivalents 20.92M Total Debt 384K Net Cash 20.54M Retained Earnings -163.1M Total Assets 37.68M Working Capital 27.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -33.36M
and capital expenditures 0, giving a free cash flow of -33.36M.
Operating Cash Flow -33.36M Capital Expenditures n/a Free Cash Flow -33.36M FCF Per Share -1.67
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -304535.71% and -300585.71%.
Gross Margin 100% Operating Margin -304535.71% Pretax Margin -300585.71% Profit Margin -300585.71% EBITDA Margin -300585.71% EBIT Margin -304535.71% FCF Margin -238292.86%
